Scilex Holding Company Public Float
Scilex Holding Company (SCLX) had Public Float of $32.40 million as of 2025-06-30, per its 10-K filed 2026-04-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-10
- 2025-06-30: Entity Public Float $32.40M.
- 2024-06-30: Entity Public Float $233.12M.
- 2023-06-30: Entity Public Float $479.56M.
- 2022-06-30: Entity Public Float $99.40M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $32.40M 10-K · filed 2026-04-10 |
| 2024-06-30 | $233.12M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $479.56M 10-K · filed 2024-03-12 |
| 2022-06-30 | $99.40M 10-K · filed 2023-03-07 |
| 2021-06-30 | $136.90M 10-K · filed 2022-02-24 |
| 2020-06-30 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |